Breaking News Instant updates and real-time market news.

GWPH

GW Pharmaceuticals

$133.10

-0.35 (-0.26%)

10:53
10/07/16
10/07
10:53
10/07/16
10:53

Goldman says marijuana-derived drug maker GW Pharma 'set to fly high'

In a note to investors this morning, Goldman Sachs analyst Salveen Richter initiated GW Pharmaceuticals (GWPH) with a Buy rating, as he expects a "solid" launch trajectory for the company's lead asset Epidiolex. Earlier this week, his peer at Leerink resumed coverage of the stock with a Buy-equivalent rating, citing also the potential uptake trajectory of its investigational drug. BACKGROUND: GW Pharmaceuticals is a pre-commercial-stage biopharmaceutical company focused on cannabis-based therapies in central nervous system disorders. Its lead asset is Epidiolex for Dravet Syndrome and Lennox-Gastaut Syndrome, two severe orphan epilepsies. 'SOLID' LAUNCH, UPCOMING CATALYSTS: Goldman Sachs' Richter initiated coverage of GW Pharmaceuticals with a Buy rating, saying it is "set to fly high." The analyst told investors that he expects a "solid" launch trajectory for the company's lead asset Epidiolex, and is modeling $1.6B in world-wide sales. Further, Richter sees GW Pharmaceuticals' shares trading higher on upcoming pipeline catalysts, including the publication of Epidiolex Phase 3 study data in Dravet syndrome in a top-tier medical journal in the fourth quarter, the American Epilepsy Society meeting, and the initiation of an Epidiolex Phase 3 study in infantile spasms in the fourth quarter, among a number of other events. GW Pharmaceuticals should submit the U.S. regulatory filing for Epidiolex in Dravet Syndrome and Lennox-Gastaut Syndrome in the first half of 2017, he noted, adding that he expects U.S. and EU launches in the second or third quarter of 2018. The analyst has a $189 price target on the shares. UPTAKE DRUG TRAJECTORY: On Tuesday, Leerink analyst Paul Matteis resumed coverage of GW Pharmaceuticals with an Outperform rating and $162 price target, saying he is "highly positive" on the potential uptake trajectory of Epidiolex, now that its approval appears mostly de-risked after three successful Phase 3 trials in Dravet Syndrome and Lennox Gastaut. Moreover, the analyst sees multiple points of optimism regarding a GW Pharmaceuticals-led global launch, including strong clinical profile and "hype" surrounding Epidiolex, significant level of unmet medical need in Dravet Syndrome and Lennox Gastaut and refractory seizures, a small subset of core prescribers, and the experience of CCO Julian Gangoli. PRICE ACTION: In morning trading, shares of GW Pharmaceuticals have slipped about 1% to $131.90.

GWPH GW Pharmaceuticals
$133.10

-0.35 (-0.26%)

10/04/16
LEER
10/04/16
INITIATION
Target $162
LEER
Outperform
GW Pharmaceuticals reinstated with an Outperform at Leerink
Leerink analyst Paul Matteis resumed coverage of GW Pharmaceuticals with an Outperform rating and $162 price target.
10/07/16
GSCO
10/07/16
INITIATION
Target $189
GSCO
Buy
GW Pharmaceuticals initiated with a Buy at Goldman
Goldman analyst Salveen Richter initiated GW Pharmaceuticals with a Buy saying he expects a solid launch trajectory for lead assets Epidiolex for Dravet Syndrome and Lennox-Gastaut Syndrome, two severe orphan epilepsies, and is modeling $1.6B in world-wide sales. Richter has a $189 price target on shares based on a blend of discounted cash flow for $161 per shares and M&A value of $349 per share.
10/07/16
GSCO
10/07/16
NO CHANGE
GSCO
Smid-cap Biotech sector upgraded to Attractive from Neutral at Goldman
Goldman analyst Salveen Richter upgraded the Smid-cap biotechnology to Attractive and said he favors and companies with near-term pipeline data or regulatory events where he has conviction.Names he recommends are Buy rated BioMarin (BMRN), bluebird bio (BLUE), GW Pharma (GWPH), Incyte (INCY), Kite (KITE), and Sage (SAGE).
10/07/16
10/07/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Zillow (ZG, Z) initiated with a Buy at Needham. 2. AMD (AMD) initiated with an Equal Weight at Barclays. 3. Aflac (AFL) was initiated with an Underperform at Credit Suisse while the firm also initiated Prudential (PRU) and Assurant (AIZ) with a Neutral. 4. Fifth Third (FITB) initiated with a Neutral at Wedbush. 5. GW Pharmaceuticals (GWPH) initiated with a Buy at Goldman. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

KSS

Kohl's

08:57
02/23/17
02/23
08:57
02/23/17
08:57
Hot Stocks
Kohl's says has 'nothing specific in mind' on M&A »

Says company in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 19

    Mar

AGN

Allergan

$246.32

-0.84 (-0.34%)

08:56
02/23/17
02/23
08:56
02/23/17
08:56
Periodicals
Allergan CEO proposes Trump lead drug price negotiations, Bloomberg reports »

Allergan CEO Brent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 04

    May

BAC

Bank of America

$24.79

0.01 (0.04%)

, TSLA

Tesla

$273.51

-3.88 (-1.40%)

08:56
02/23/17
02/23
08:56
02/23/17
08:56
Options
Notable open interest changes for February 23rd »

Wednesday's total…

BAC

Bank of America

$24.79

0.01 (0.04%)

TSLA

Tesla

$273.51

-3.88 (-1.40%)

JCP

J.C. Penney

$7.05

-0.01 (-0.14%)

FB

Facebook

$136.12

2.4 (1.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 24

    Feb

  • 28

    Feb

  • 28

    Feb

  • 06

    Mar

  • 19

    Mar

  • 28

    Mar

TNC

Tennant

$70.10

-1.9 (-2.64%)

08:55
02/23/17
02/23
08:55
02/23/17
08:55
Hot Stocks
Breaking Hot Stocks news story on Tennant 

Tennant trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

SFTBF

SoftBank

$76.90

-0.3575 (-0.46%)

, VOD

Vodafone

08:55
02/23/17
02/23
08:55
02/23/17
08:55
Periodicals
SoftBank in talks to buy stake in Vodafone Indian unit, The Economic Times says »

Softbank (SFTBF) could…

SFTBF

SoftBank

$76.90

-0.3575 (-0.46%)

VOD

Vodafone

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:55
02/23/17
02/23
08:55
02/23/17
08:55
General news
The 6k U.S. initial claims rise to 244k »

The 6k U.S. initial…

THG

Hanover Insurance

$91.08

0.43 (0.47%)

08:55
02/23/17
02/23
08:55
02/23/17
08:55
Conference/Events
Hanover Insurance to host investor day »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 05

    Mar

HNR

Harvest Natural

$6.68

0.04 (0.60%)

08:55
02/23/17
02/23
08:55
02/23/17
08:55
Conference/Events
Harvest Natural to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

TNC

Tennant

$70.10

-1.9 (-2.64%)

08:54
02/23/17
02/23
08:54
02/23/17
08:54
Hot Stocks
Tennant to reduce 3% of global workforce »

Tennant announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

TNC

Tennant

$70.10

-1.9 (-2.64%)

08:53
02/23/17
02/23
08:53
02/23/17
08:53
Earnings
Tennant sees 2017 adjusted EPS $2.50-$2.70, consensus $2.83 »

On an as adjusted and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

STNG

Scorpio Tankers

$4.28

-0.01 (-0.23%)

08:53
02/23/17
02/23
08:53
02/23/17
08:53
Upgrade
Scorpio Tankers rating change  »

Scorpio Tankers upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

KSS

Kohl's

08:52
02/23/17
02/23
08:52
02/23/17
08:52
Hot Stocks
Kohl's sees significant improvement in Q1 gross margin »

Sees significant…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 19

    Mar

TNC

Tennant

$70.10

-1.9 (-2.64%)

08:51
02/23/17
02/23
08:51
02/23/17
08:51
Earnings
Tennant reports Q4 EPS 85c, consensus 76c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

LMRK

Landmark Infrastructure

08:50
02/23/17
02/23
08:50
02/23/17
08:50
Syndicate
Breaking Syndicate news story on Landmark Infrastructure »

Landmark Infrastructure…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Mar

KSS

Kohl's

, UA

Under Armour

$19.78

0.09 (0.46%)

08:50
02/23/17
02/23
08:50
02/23/17
08:50
Hot Stocks
Kohl's CEO believes uncertainty in sector will continue »

Kohl's (KSS) says…

KSS

Kohl's

UA

Under Armour

$19.78

0.09 (0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 19

    Mar

ABBV

AbbVie

$61.36

-0.47 (-0.76%)

, AGN

Allergan

$246.32

-0.84 (-0.34%)

08:50
02/23/17
02/23
08:50
02/23/17
08:50
Conference/Events
Piper Jaffray healthcare/pharma analyst holds analyst/industry conference call »

Analyst Schimmer, along…

ABBV

AbbVie

$61.36

-0.47 (-0.76%)

AGN

Allergan

$246.32

-0.84 (-0.34%)

BMY

Bristol-Myers

$55.35

0.57 (1.04%)

ENTA

Enanta

$28.18

-0.36 (-1.26%)

GALT

Galectin Therapeutics

$1.71

-0.23 (-11.86%)

GILD

Gilead

$68.83

-0.46 (-0.66%)

GLMD

Galmed

$4.09

-0.16 (-3.76%)

ICPT

Intercept

$122.79

-2.66 (-2.12%)

MRK

Merck

$65.29

-0.19 (-0.29%)

RGLS

Regulus

$1.08

-0.025 (-2.27%)

VKTX

Viking Therapeutics

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 23

    Feb

  • 02

    Mar

  • 06

    Mar

  • 06

    Mar

  • 08

    Mar

  • 09

    Mar

  • 15

    Mar

  • 17

    Mar

  • 01

    Apr

  • 04

    May

  • 10

    May

  • 27

    May

  • 14

    Jun

08:50
02/23/17
02/23
08:50
02/23/17
08:50
General news
Atlanta Fed centrist Lockhart sees the pendulum swinging »

Atlanta Fed centrist…

W

Wayfair

$41.26

1 (2.48%)

08:49
02/23/17
02/23
08:49
02/23/17
08:49
Hot Stocks
Breaking Hot Stocks news story on Wayfair »

Wayfair down 10.3% after…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

TWX

Time Warner

$96.32

-0.1 (-0.10%)

, T

AT&T

$41.59

-0.14 (-0.34%)

08:46
02/23/17
02/23
08:46
02/23/17
08:46
Periodicals
Time Warner IR head to lead AT&T integration, THR reports »

Time Warner (TWX) head of…

TWX

Time Warner

$96.32

-0.1 (-0.10%)

T

AT&T

$41.59

-0.14 (-0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 06

    Mar

QQQ

NASDAQ 100 Index Tracking Stock

$130.50

0.05 (0.04%)

, ETE

Energy Transfer Equity

$18.92

-0.13 (-0.68%)

08:46
02/23/17
02/23
08:46
02/23/17
08:46
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

QQQ

NASDAQ 100 Index Tracking Stock

$130.50

0.05 (0.04%)

ETE

Energy Transfer Equity

$18.92

-0.13 (-0.68%)

FIT

Fitbit

$5.88

-0.16 (-2.65%)

NAK

Northern Dynasty

$1.39

-0.27 (-16.27%)

BX

Blackstone

$30.32

-0.23 (-0.75%)

PCLN

Priceline

$1,651.74

4.74 (0.29%)

TBT

ProShares UltraShort 20+ yr Trsry

$39.71

-0.14 (-0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 27

    Feb

  • 28

    Feb

TNC

Tennant

$70.10

-1.9 (-2.64%)

08:45
02/23/17
02/23
08:45
02/23/17
08:45
Hot Stocks
Tennant announces agreement with Ambienta to acquire IPC Group for $350M »

Tennant Company announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

08:45
02/23/17
02/23
08:45
02/23/17
08:45
General news
Treasury Action: yields remained downwardly biased »

Treasury Action: yields…

08:45
02/23/17
02/23
08:45
02/23/17
08:45
General news
FHFA House Price Index M/M change to be reported at 09:00 »

December FHFA House Price…

ICON

Iconix Brand

$9.18

-0.03 (-0.33%)

08:43
02/23/17
02/23
08:43
02/23/17
08:43
Recommendations
Iconix Brand analyst commentary  »

Roth Capital remains a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHLX

Shell Midstream

$33.19

-0.75 (-2.21%)

08:43
02/23/17
02/23
08:43
02/23/17
08:43
Earnings
Shell Midstream reports Q4 EPS 34c, consensus 35c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.